TP53 and neoplasm: Transcription factors such as NF‐E2‐related factor‐2 (Nrf2) promote resistance to ferroptosis by upregulating antioxidant responses, while tumor suppressors like p53 can either enhance or inhibit ferroptosis depending on cellular context [21].